Results
4056
Companies which are more than 50% undervalued based on analyst price target.
4,056 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
BILL | US$57.95 | -5.1% | -5.5% | US$6.1b | US$88.40 | PE72.2x | E-8.3% | n/a | Software | ||
AC | ₱556.00 | -0.7% | -22.9% | ₱353.3b | ₱844.86 | PE9.1x | E20.0% | 1.5% | Capital Goods | ||
GRF | €9.47 | 7.9% | -12.3% | €5.8b | €15.99 | PE39.9x | E30.3% | n/a | Pharmaceuticals & Biotech | ||
3037 | NT$128.00 | 0% | -32.3% | NT$198.7b | NT$210.80 | PE24.7x | E62.4% | 2.3% | Tech | ||
NEXI | €4.73 | 3.6% | -32.7% | €5.8b | €7.21 | PS0.9x | E74.8% | 0% | Diversified Financials | ||
601117 | CN¥7.12 | -4.2% | 4.6% | CN¥44.0b | CN¥10.96 | PE7.8x | E9.9% | 2.5% | Capital Goods | ||
600426 | CN¥20.28 | -5.3% | -25.4% | CN¥43.9b | CN¥31.42 | PE11.6x | E21.1% | 3.0% | Materials | ||
RENT3 | R$30.45 | -0.7% | -43.6% | R$33.9b | R$57.34 | PE19.2x | E39.5% | 5.2% | Transportation | ||
ZETA | US$23.08 | 8.3% | 129.7% | US$5.9b | US$36.92 | PS6.1x | E125.6% | n/a | Software | ||
002422 | CN¥27.19 | -0.9% | 5.7% | CN¥42.6b | CN¥43.29 | PE14.6x | E10.6% | 1.9% | Pharmaceuticals & Biotech | ||
LNTH | US$81.39 | -0.9% | 43.5% | US$5.8b | US$133.46 | PE13.2x | E12.8% | n/a | Healthcare | ||
002459 | CN¥12.40 | -3.7% | -32.0% | CN¥42.0b | CN¥19.02 | PS0.5x | E59.3% | 4.5% | Semiconductors | ||
SAHOL | ₺99.30 | 0.9% | 23.0% | ₺208.6b | ₺154.19 | PB0.8x | E108.1% | 3.0% | Banks | ||
2897 | JP¥2,918.00 | -4.6% | -33.7% | JP¥866.7b | JP¥4,505.00 | PE17.6x | E6.3% | 2.4% | Food, Beverage & Tobacco | ||
PRIO3 | R$39.01 | -1.3% | -17.0% | R$32.7b | R$61.99 | PE6.7x | E23.0% | n/a | Energy | ||
ELAN | US$11.24 | -1.2% | -30.4% | US$5.6b | US$16.92 | PE27.1x | E1.6% | n/a | Pharmaceuticals & Biotech | ||
BRFS3 | R$19.03 | -5.9% | 36.6% | R$31.4b | R$28.65 | PE9.5x | E-8.8% | 3.1% | Food, Beverage & Tobacco | ||
ANF | US$105.11 | -3.5% | -10.4% | US$5.5b | US$187.40 | PE9.9x | E4.9% | 0% | Retail | ||
600161 | CN¥20.12 | -0.9% | -12.7% | CN¥39.7b | CN¥30.53 | PE31.2x | E19.7% | 0.6% | Pharmaceuticals & Biotech | ||
MARA | US$15.78 | -2.8% | -31.1% | US$5.4b | US$26.92 | PE32.5x | E-35.8% | n/a | Software | ||
CYTK | US$46.40 | 10.0% | -39.3% | US$5.4b | US$79.55 | PS1701.1x | E39.3% | n/a | Pharmaceuticals & Biotech | ||
JD. | UK£0.81 | -6.9% | -27.9% | UK£4.2b | UK£1.25 | PE12.3x | E23.2% | 1.1% | Retail | ||
688472 | CN¥10.38 | -0.5% | -25.2% | CN¥38.4b | CN¥19.43 | PE19x | E25.9% | 1.2% | Semiconductors | ||
FB | ₱51.10 | -3.0% | 2.2% | ₱304.9b | ₱78.50 | PE11.5x | E1.9% | 6.4% | Food, Beverage & Tobacco |